Published in Surgery Litigation and Law Weekly, January 19th, 2007
Study 1: Researchers detail in "Preemptive antifungal therapy: still a way to go," new data in antifungals. According to a study from Leuven, Belgium, "Early treatment of invasive mold infections improves the outcome. Therapy is often delayed, however, because available diagnostic tools such as culture, microscopy and conventional radiology lack sensitivity; consequently, empirical initiation of antifungal therapy has been advocated, particularly for patients with prolonged unexplained neutropenic fever."
"Much recent progress has been made in the development...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.